NASDAQ:MRAI Marpai (MRAI) Stock Price, News & Analysis → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free MRAI Stock Alerts $2.18 +0.05 (+2.35%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$2.06▼$2.2150-Day Range$1.34▼$2.8152-Week Range$0.33▼$3.46Volume45,685 shsAverage Volume131,431 shsMarket Capitalization$22.45 millionP/E RatioN/ADividend YieldN/APrice Target$6.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get Marpai alerts: Email Address Marpai MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside175.2% Upside$6.00 Price TargetShort InterestHealthy2.27% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.33Based on 2 Articles This WeekInsider TradingAcquiring Shares$1.50 M Bought Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.38 out of 5 starsBusiness Services Sector109th out of 306 stocksMiscellaneous Health & Allied Services, Not Elsewhere Classified Industry5th out of 6 stocks 3.5 Analyst's Opinion Consensus RatingMarpai has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageMarpai has only been the subject of 1 research reports in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted2.27% of the float of Marpai has been sold short.Short Interest Ratio / Days to CoverMarpai has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Marpai has recently decreased by 42.02%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldMarpai does not currently pay a dividend.Dividend GrowthMarpai does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for MRAI. Previous Next 2.4 News and Social Media Coverage News SentimentMarpai has a news sentiment score of 0.33. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Business Services companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Marpai this week, compared to 1 article on an average week.Search InterestOnly 11 people have searched for MRAI on MarketBeat in the last 30 days. This is a decrease of -8% compared to the previous 30 days.MarketBeat Follows22 people have added Marpai to their MarketBeat watchlist in the last 30 days. This is an increase of 1,000% compared to the previous 30 days. Previous Next 4.2 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Marpai insiders have bought more of their company's stock than they have sold. Specifically, they have bought $1,501,500.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders61.30% of the stock of Marpai is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions49.75% of the stock of Marpai is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Marpai is -0.49, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Marpai is -0.49, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About Marpai Stock (NASDAQ:MRAI)Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, health savings account administration, bill review and cost containment services. It also develops artificial intelligence and healthcare technology. Marpai, Inc. was incorporated in 2021 and is headquartered in New York, New York.Read More MRAI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MRAI Stock News HeadlinesApril 8, 2024 | marketbeat.comThe 5 Hottest CEO Stock Purchases So Far This YearInsider buying is good. It shows management's confidence in a business, helping to support investor sentiment, and no insider is more significant than the CEO.April 8, 2024 | marketbeat.comThe 5 Hottest CEO Stock Purchases So Far This Year (MRAI)Insider buying is a telling indicator for investors, and no insider is as significant as the CEO. This is a look at the five hottest CEO buys this year.April 27, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.April 24, 2024 | prnewswire.comMARPAI INC. BOLSTERS SALES TEAM WITH TWO WORLD-CLASS EXECUTIVESApril 20, 2024 | americanbankingnews.comMarpai (NASDAQ:MRAI) Stock Price Down 6%April 18, 2024 | investing.comMarpai secures $11.83 million in convertible notesApril 16, 2024 | prnewswire.comMARPAI INC. ANNOUNCES SALE OF $11.83 MILLION CONVERTIBLE NOTESApril 4, 2024 | benzinga.comMarpai Stock (NASDAQ:MRAI), Quotes and News SummaryApril 27, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.March 29, 2024 | seekingalpha.comMarpai, Inc. (MRAI) Q4 2023 Earnings Call TranscriptMarch 29, 2024 | investing.comEarnings call: Marpai reports mixed Q4 and FY 2023 financial resultsMarch 29, 2024 | finance.yahoo.comQ4 2023 Marpai Inc Earnings CallMarch 28, 2024 | finance.yahoo.comMarpai, Inc. (NASDAQ:MRAI) Q4 2023 Earnings Call TranscriptMarch 27, 2024 | finance.yahoo.comMARPAI REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTSMarch 13, 2024 | finance.yahoo.comNASDAQ PANEL GRANTS MARPAI'S REQUEST FOR EXTENSION TO COMPLY WITH CONTINUED LISTING REQUIREMENTSMarch 7, 2024 | investing.comMarpai secures deal to expand in the Southeast marketMarch 6, 2024 | finance.yahoo.comMARPAI ANNOUNCES "OFF-CYCLE" NEW CLIENT AGREEMENTMarch 6, 2024 | finance.yahoo.comMARPAI ANNOUNCES PRELIMINARY UNAUDITED FINANCIAL RESULTS FOR FOURTH QUARTER AND FULL YEAR 2023February 9, 2024 | markets.businessinsider.comMarpai Adjusts AXA Deal Terms, Sells Future ReceiptsFebruary 8, 2024 | finance.yahoo.comMARPAI ANNOUNCES KEY FINANCIAL AGREEMENTSJanuary 20, 2024 | finance.yahoo.comMarpai CEO & Director Acquires 84% More StockJanuary 18, 2024 | msn.comWhy Is Marpai (MRAI) Stock Up 27% Today?January 12, 2024 | msn.comMarpai appoints John Powers as its CEOJanuary 12, 2024 | finance.yahoo.comMARPAI HIRES JOHN POWERS AS PRESIDENTDecember 18, 2023 | finance.yahoo.comFurther Upside For Marpai, Inc. (NASDAQ:MRAI) Shares Could Introduce Price Risks After 93% BounceDecember 14, 2023 | morningstar.comMarpai Inc Class ADecember 6, 2023 | finance.yahoo.comMARPAI, INC. REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE COMPLIANCESee More Headlines Receive MRAI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Marpai and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/26/2024Today4/27/2024Next Earnings (Estimated)5/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorBusiness Services Industry Miscellaneous health & allied services, not elsewhere classified Sub-IndustryN/A Current SymbolNASDAQ:MRAI CUSIPN/A CIK1844392 Webwww.marpaihealth.com Phone646-303-3483FaxN/AEmployees162Year FoundedN/APrice Target and Rating Average Stock Price Target$6.00 High Stock Price Target$6.00 Low Stock Price Target$6.00 Potential Upside/Downside+175.2%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($4.41) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-28,750,000.00 Net Margins-77.38% Pretax Margin-78.16% Return on EquityN/A Return on Assets-75.05% Debt Debt-to-Equity RatioN/A Current Ratio0.82 Quick Ratio0.82 Sales & Book Value Annual Sales$37.15 million Price / Sales0.60 Cash FlowN/A Price / Cash FlowN/A Book Value($1.72) per share Price / Book-1.27Miscellaneous Outstanding Shares10,300,000Free Float3,986,000Market Cap$22.45 million OptionableNo Data Beta5.41 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Damien Francis Lamendola (Age 67)CEO & Director Mr. Steve Johnson (Age 53)CFO & Company Secretary Mr. John Powers (Age 56)President & COO Dr. Eli David (Age 42)Co-Founder & Chief Science Advisor Ms. Pamela BurnsVice President of Enterprise SalesKey CompetitorsSyntec OpticsNASDAQ:OPTXUrgent.lyNASDAQ:ULYAppTech PaymentsNASDAQ:APCXStran & Company, Inc.NASDAQ:SWAGPrimechNASDAQ:PMECView All CompetitorsInsidersDamien LamendolaBought 910,000 shares on 3/7/2024Total: $1.50 M ($1.65/share)Damien LamendolaBought 1,100,000 shares on 1/16/2024Total: $1.01 M ($0.92/share)Robert M PonsBought 12,100 shares on 1/16/2024Total: $11,132.00 ($0.92/share)Damien LamendolaBought 150,000 shares on 12/14/2023Total: $295,500.00 ($1.97/share)Yaron EitanBought 50,000 shares on 12/14/2023Total: $98,500.00 ($1.97/share)View All Insider Transactions MRAI Stock Analysis - Frequently Asked Questions Should I buy or sell Marpai stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Marpai in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" MRAI shares. View MRAI analyst ratings or view top-rated stocks. What is Marpai's stock price target for 2024? 1 brokers have issued twelve-month price objectives for Marpai's stock. Their MRAI share price targets range from $6.00 to $6.00. On average, they predict the company's stock price to reach $6.00 in the next twelve months. This suggests a possible upside of 175.2% from the stock's current price. View analysts price targets for MRAI or view top-rated stocks among Wall Street analysts. How have MRAI shares performed in 2024? Marpai's stock was trading at $1.75 at the beginning of 2024. Since then, MRAI stock has increased by 24.6% and is now trading at $2.18. View the best growth stocks for 2024 here. Are investors shorting Marpai? Marpai saw a decrease in short interest during the month of April. As of April 15th, there was short interest totaling 116,600 shares, a decrease of 42.0% from the March 31st total of 201,100 shares. Based on an average daily volume of 453,500 shares, the days-to-cover ratio is currently 0.3 days. Approximately 2.3% of the shares of the stock are sold short. View Marpai's Short Interest. When is Marpai's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024. View our MRAI earnings forecast. How were Marpai's earnings last quarter? Marpai, Inc. (NASDAQ:MRAI) issued its quarterly earnings results on Tuesday, March, 26th. The company reported ($0.65) earnings per share (EPS) for the quarter. The company earned $8.71 million during the quarter. When did Marpai's stock split? Marpai's stock reverse split before market open on Thursday, June 29th 2023. The 1-4 reverse split was announced on Thursday, June 29th 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, June 29th 2023. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split. What guidance has Marpai issued on next quarter's earnings? Marpai issued an update on its FY 2023 earnings guidance on Wednesday, March, 6th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $37.2 million-$37.2 million, compared to the consensus revenue estimate of $34.6 million. When did Marpai IPO? Marpai (MRAI) raised $25 million in an IPO on Wednesday, October 27th 2021. The company issued 6,300,000 shares at $4.00 per share. ThinkEquity served as the underwriter for the IPO. How do I buy shares of Marpai? Shares of MRAI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:MRAI) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingProtect Your Bank Account Before It’s Too LateWeiss RatingsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Marpai, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
